rs200400235

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_021098.3(CACNA1H):​c.4045G>A​(p.Ala1349Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000675 in 1,600,820 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A1349A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000098 ( 0 hom., cov: 35)
Exomes 𝑓: 0.000064 ( 1 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

7
10
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 3.17
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.035609752).
BP6
Variant 16-1210793-G-A is Benign according to our data. Variant chr16-1210793-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 529637.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.0000984 (15/152364) while in subpopulation EAS AF= 0.00289 (15/5192). AF 95% confidence interval is 0.00178. There are 0 homozygotes in gnomad4. There are 10 alleles in male gnomad4 subpopulation. Median coverage is 35. This position pass quality control queck.
BS2
High AC in GnomAd4 at 15 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.4045G>A p.Ala1349Thr missense_variant Exon 21 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.4045G>A p.Ala1349Thr missense_variant Exon 21 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000565831.6 linkc.4045G>A p.Ala1349Thr missense_variant Exon 20 of 33 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000638323.1 linkc.4006G>A p.Ala1336Thr missense_variant Exon 21 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000569107.5 linkc.268G>A p.Ala90Thr missense_variant Exon 4 of 17 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000564231.5 linkc.268G>A p.Ala90Thr missense_variant Exon 4 of 18 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000562079.5 linkc.268G>A p.Ala90Thr missense_variant Exon 4 of 17 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000637236.2 linkn.*15G>A non_coding_transcript_exon_variant Exon 5 of 6 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.4045G>A non_coding_transcript_exon_variant Exon 21 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000640028.1 linkn.*1958G>A non_coding_transcript_exon_variant Exon 21 of 35 5 ENSP00000491488.1 A0A1W2PQ19
CACNA1HENST00000637236.2 linkn.*15G>A 3_prime_UTR_variant Exon 5 of 6 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000640028.1 linkn.*1958G>A 3_prime_UTR_variant Exon 21 of 35 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.0000985
AC:
15
AN:
152246
Hom.:
0
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00288
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000290
AC:
69
AN:
237694
Hom.:
0
AF XY:
0.000268
AC XY:
35
AN XY:
130462
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00381
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000169
GnomAD4 exome
AF:
0.0000642
AC:
93
AN:
1448456
Hom.:
1
Cov.:
39
AF XY:
0.0000652
AC XY:
47
AN XY:
721102
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00229
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000332
GnomAD4 genome
AF:
0.0000984
AC:
15
AN:
152364
Hom.:
0
Cov.:
35
AF XY:
0.000134
AC XY:
10
AN XY:
74510
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00289
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000229
Hom.:
0
Bravo
AF:
0.000132
ExAC
AF:
0.000281
AC:
34
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1
Jan 21, 2020
GeneDx
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Oct 18, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Uncertain
0.047
T
BayesDel_noAF
Pathogenic
0.30
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.84
D;.;.;.
Eigen
Uncertain
0.51
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D;D;.
M_CAP
Pathogenic
0.49
D
MetaRNN
Benign
0.036
T;T;T;T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
2.9
M;.;M;M
PrimateAI
Uncertain
0.52
T
PROVEAN
Uncertain
-2.9
D;.;D;D
REVEL
Pathogenic
0.86
Sift
Uncertain
0.0010
D;.;D;D
Sift4G
Uncertain
0.0040
D;.;D;D
Polyphen
0.99
D;.;D;D
Vest4
0.87
MVP
0.96
ClinPred
0.14
T
GERP RS
4.2
Varity_R
0.58
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200400235; hg19: chr16-1260793; API